510(k) K022331

ADVIA 120 HEMATOLOGY SYSTEM, CEREBROSPINAL FLUID METHOD by Bayer Diagnostics Corp. — Product Code GKL

K022331 is an FDA 510(k) premarket notification submitted by Bayer Diagnostics Corp. for the device "ADVIA 120 HEMATOLOGY SYSTEM, CEREBROSPINAL FLUID METHOD". The FDA issued a decision of Substantially Equivalent on September 11, 2002. The device falls under product code GKL (Counter, Cell, Automated (Particle Counter)), a Class II device regulated under 21 CFR 864.5200. Bayer Diagnostics Corp. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
September 11, 2002
Date Received
July 18, 2002
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Counter, Cell, Automated (Particle Counter)
Device Class
Class II
Regulation Number
864.5200
Review Panel
HE
Submission Type